Dynamic interplay between tumour, stroma and immune system can drive or prevent tumour progression RJ Seager, C Hajal, F Spill, RD Kamm, MH Zaman Convergent science physical oncology 3 (3), 034002, 2017 | 147 | 2017 |
Integrated in silico and 3D in vitro model of macrophage migration in response to physical and chemical factors in the tumor microenvironment SWL Lee, RJ Seager, F Litvak, F Spill, JL Sieow, PH Leong, D Kumar, ... Integrative Biology 12 (4), 90-108, 2020 | 57 | 2020 |
Solid dissolution in a fluid solvent is characterized by the interplay of surface area-dependent diffusion and physical fragmentation RJ Seager, AJ Acevedo, F Spill, MH Zaman Scientific reports 8 (1), 7711, 2018 | 54 | 2018 |
Visceral obesity promotes lung cancer progression—toward resolution of the obesity paradox in lung cancer J Barbi, SK Patnaik, S Pabla, R Zollo, RJ Smith Jr, SN Sass, A Srinivasan, ... Journal of Thoracic Oncology 16 (8), 1333-1348, 2021 | 43 | 2021 |
A scalable high-throughput targeted next-generation sequencing assay for comprehensive genomic profiling of solid tumors JM Conroy, S Pabla, ST Glenn, RJ Seager, E Van Roey, S Gao, ... PLoS One 16 (12), e0260089, 2021 | 28 | 2021 |
Integration of tumor inflammation, cell proliferation, and traditional biomarkers improves prediction of immunotherapy resistance and response S Pabla, RJ Seager, E Van Roey, S Gao, C Hoefer, MK Nesline, ... Biomarker Research 9 (1), 56, 2021 | 23 | 2021 |
Dynamic interplay between tumour, stroma and immune system can drive or prevent tumour progression. Converg Sci Phys Oncol. 2017; 3: 034002 RJ Seager, C Hajal, F Spill, RD Kamm, MH Zaman Journal of Immunology Research 3046379, 2019 | 11 | 2019 |
Obesity-Specific Association of Statin Use and Reduced Risk of Recurrence of Early Stage NSCLC SK Patnaik, C Petrucci, J Barbi, RJ Seager, S Pabla, S Yendamuri JTO Clinical and Research Reports 2 (12), 100254, 2021 | 5 | 2021 |
Antimicrobial resistance trends from a hospital and diagnostic facility in Lahore, Pakistan: A five-year retrospective analysis (2014-2018) C Ching, S Nizamuddin, F Rasheed, RJ Seager, F Litvak, F Sultan, ... medRxiv, 19012617, 2019 | 4 | 2019 |
Risk analysis of the residual heat removal system at south Texas project with a special focus on breach of containment M Solom, C Chance, C Pannier, R Seager, A Lee, J Green, T Duong, ... International Conference on Nuclear Engineering 44960, 321-331, 2012 | 4 | 2012 |
Visceral obesity in non-small cell lung cancer L Nitsche, Y Vedire, E Kannisto, X Wang, RJ Seager, S Pabla, SK Patnaik, ... Cancers 14 (14), 3450, 2022 | 3 | 2022 |
Cancer testis antigen burden: A novel predictive biomarker for immunotherapy in solid tumors S Pabla, R Seager, YH Lee, E Van Roey, S Gao, V Giamo, B Burgher, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | 3 | 2021 |
Immunologic Factors Associated with Differential Response to Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer RJ Seager, H Ko, S Pabla, MF Senosain, P Kalinski, E Van Roey, S Gao, ... Journal of Personalized Medicine 14 (5), 481, 2024 | 1 | 2024 |
Cancer testis antigen burden (CTAB): a novel biomarker of tumor-associated antigens in lung cancer RJ Seager, MF Senosain, E Van Roey, S Gao, P DePietro, MK Nesline, ... Journal of Translational Medicine 22 (1), 141, 2024 | 1 | 2024 |
LAG3 landscape in solid tumors and its association with immunotherapy outcomes in non-small cell lung cancer. R Seager, MF Senosain, E Van Roey, S Gao, P DePietro, MK Nesline, ... Journal of Clinical Oncology 41 (16_suppl), e21113-e21113, 2023 | 1 | 2023 |
77 Prevalence of secondary immunotherapeutic targets in the absence of established immune biomarkers in solid tumors P DePietro, M Nesline, YH Lee, RJ Seager, E Van Roey, S Gao, V Giamo, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), A86-A86, 2021 | 1 | 2021 |
SO-5 Tumor inflammation and proliferative status as biomarkers in gastroesophageal adenocarcinoma S Mukherjee, R Seager, Y Lee, J Conroy, S Pabla Annals of Oncology 32, S204, 2021 | 1 | 2021 |
64 Cancer testis antigen co-expression landscape in solid tumors RJ Seager, E Van Roey, S Gao, J Andreas, V Giamo, B Burgher, F Lenzo, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | 1 | 2020 |
Immune and cancer testis antigen landscape in sarcoma A Grand’Maison, RJ Seager, YH Lee, MK Nesline, JM Conroy, S Pabla | 1 | |
Synergistic interactions between TGF-β1-and TNFα-induced signaling in cancer cells are the result of TAK1-and Smad7-mediated crosstalk RJ Seager, F Spill, R Li, RD Kamm, MH Zaman review, 0 | 1 | |